You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 2, 2026

Profile for Serbia Patent: 55143


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Serbia Patent: 55143

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Mar 5, 2030 Pfizer VELSIPITY etrasimod arginine
⤷  Start Trial Jul 22, 2029 Pfizer VELSIPITY etrasimod arginine
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Serbia Patent RS55143

Last updated: September 11, 2025

Introduction

Patent RS55143, granted in Serbia, pertains to a pharmaceutical invention with potential implications in drug manufacturing, formulation, and therapeutic application. Understanding the scope and claims of this patent, along with the broader patent landscape, is essential for stakeholders including pharmaceutical companies, generic manufacturers, legal professionals, and R&D entities. This detailed analysis aims to dissect the patent's substantive technical content, its territorial and strategic importance, and its positioning within the global patent ecosystem.

Patent Overview

Serbia Patent RS55143 was granted to protect a specific pharmaceutical formulation, process, or therapeutic compound. While precise details depend on the patent's textual content, typical patent structures include claims defining the scope of protection, descriptive sections explaining the invention, and drawings if applicable. The patent's filing date, priority dates, and expiry terms influence its strategic value and potential licensing or litigation activity.

Scope of the Patent

Claims Analysis

The core of any patent lies in its claims. They delineate the legally enforceable boundary of the invention. For RS55143, the claims likely encompass one or more of the following:

  • Compound Claims: These define the chemical entities or molecules, often specifying structural formulas, stereochemistry, or compositions with particular substituents.

  • Method Claims: Cover procedures for synthesizing, preparing, or using the pharmaceutical compound or formulation.

  • Formulation Claims: Protect specific dosage forms, delivery systems, or excipient combinations enhancing stability, bioavailability, or patient compliance.

  • Use Claims: Encompass the therapeutic application of the drug for particular indications or patient populations.

An in-depth review of the claims reveals their scope breadth. For example, broad compound claims may cover entire classes, while narrower process claims limit protection to specific synthetic routes. The language's precision (e.g., "comprising," "consisting of") impacts claim breadth and enforceability.

Claim Hierarchy and Dependent Claims

Dependent claims refine the independent claims, providing fallback positions and additional protective layers. Examining these indicates potential areas for patent challenges or design-arounds. For RS55143, claims may be structured to cover multiple aspects — from specific compounds to their use in treating particular diseases.

Technical Features and Innovations

The claims likely emphasize inventive features such as improved bioavailability, reduced side effects, simplified synthesis, or novel therapeutic combinations. These features ensure the patent's novelty and inventive step over prior art.

Patent Landscape

National and Regional Context

Serbia, as a member of the Balkan region, follows harmonized patent standards aligned with the European Patent Convention (EPC). While RS55143 is a national patent, its strategic value is enhanced if it overlaps with European or international patent families.

Global Patent Family

Analyzing patent family data reveals whether the same invention is protected in major markets like the EU, US, or China. This influences licensing strategies and potential global patent enforcement.

Prior Art and Patentability

To assess novelty and inventive step, prior art searches are critical. Relevant prior art includes earlier patents, scientific publications, and existing commercial drugs. If RS55143 claims a novel compound or process not disclosed previously, it maintains a robust patent position.

Potential Patent Thickets and Freedom-to-Operate

The pharmaceutical landscape often involves overlapping patents (patent thickets). Analyzing whether RS55143 intersects with other patents helps determine the freedom to manufacture or market the protected invention, especially considering patent expirations and licensing opportunities.

Pending Applications and Litigation

Any subsequent filings referencing RS55143 or legal disputes over its claims indicate its strategic importance. Stakeholders should monitor opposition or invalidation proceedings, which can influence enforcement strength.

Strategic Implications

The scope of RS55143 positioning hints at potential for:

  • Market exclusivity for the protected formulation or method within Serbia and extended regions.

  • Licensing opportunities, especially if the patent covers a therapeutically valuable or innovative compound.

  • Research and Development leverage in formulating improved versions or combination therapies.

  • Competitive barrier deterring generic entry until patent expiry or invalidation.

Legal and Commercial Considerations

Despite its patent protection, ongoing patent validity depends on maintenance fee payments, possible legal challenges, and prudent patent management. Additionally, the patent's enforceability will depend on the clarity of claims and evidence of infringement.


Key Takeaways

  • Patent RS55143 likely covers specific pharmaceutical compounds or formulations with claims structured to include compositions, methods, or uses, offering strategic exclusivity in Serbia.

  • Claim language and scope determine the patent’s breadth; broad claims provide stronger protection but may be more vulnerable to prior art challenges.

  • Global patent family analysis is crucial for assessing international commercial potential; national patents like RS55143 serve as a foundation for broader patent rights.

  • Understanding the broader patent landscape — including prior art, potential overlaps, and litigation history — informs risk mitigation and strategic positioning.

  • For patentees and licensees, this patent offers a potential barrier to entry for competitors but requires continuous management to maintain enforceability.


FAQs

Q1. What does the scope of a patent's claims indicate about its strength?
A1. The scope reflects how broadly the invention is protected. Broader claims provide wider protection but often face higher scrutiny for novelty and inventive step, whereas narrower claims may be easier to defend but limit market exclusivity.

Q2. How does the patent landscape influence drug development strategies in Serbia?
A2. It informs companies about existing protection, potential patent conflicts, and opportunities for licensing or innovation, guiding R&D choices and market entry planning.

Q3. What is the significance of patent family analysis for RS55143?
A3. It determines whether the invention is protected in multiple jurisdictions, impacting its global market potential and enforcement capabilities.

Q4. Can RS55143 be challenged or invalidated?
A4. Yes, through opposition procedures, prior art submissions, or legal challenges based on lack of novelty or inventive step, depending on national laws and procedural options.

Q5. Why is continuous patent management important for pharmaceutical inventions?
A5. Maintaining legal validity, defending against infringers, and leveraging patent rights for licensing or commercialization require diligent patent prosecution and enforcement strategies.


References

  1. Serbian Intellectual Property Office. Patent RS55143 Details.
  2. European Patent Office. Guidelines on Patent Claims.
  3. World Intellectual Property Organization. Patent Landscape Reports.
  4. PatentScope. Global Patent Family Data.
  5. Scholarly articles on pharmaceutical patent strategies and patent law.

Note: Specific technical details, such as the exact chemical structure, therapeutic indication, or process steps, can be obtained directly from the patent document RS55143 upon review.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.